Andréa Buchmuller

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial

Ingrid M. Bistervels, Andréa Buchmuller, Hanke M.G. Wiegers et al. · The Lancet · 2022 · 111 citations · Full text

Medicine, Obstetrics, Pharmacotherapy +16

Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation

HR Büller, R Cariou, Alexander Gallus et al. · Pure Amsterdam UMC · 2000 · 82 citations

Medicine, Pharmacology, Pharmacotherapy +17

Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial

Françis Couturaud, Jeannot Schmidt, Olivier Sanchez et al. · The Lancet · 2025 · 71 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Diagnosis of Pulmonary Embolism in Patients with Proximal Deep Vein Thrombosis

Philippe Girard, M. Décousus, Silvy Laporte et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 69 citations

Medicine, Clinical Sciences, Internal Medicine +17

Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses

Suzanne M. Bleker, Andréa Buchmuller, Céline Chauleur et al. · Thrombosis Research · 2016 · 52 citations

Medicine, Obstetrics, Pharmacotherapy +17